In this podcast, Gregory Sayuk, MD, MPH, speaks about the different types of treatment options available for patients with irritable bowel syndrome (IBS) and irritable bowel syndrome with diarrhea (IBS-D),...
In this podcast, Samir Shah, MD, speaks about the controversies in dysplasia surveillance in inflammatory bowel disease (IBD), virtual chromoendoscopy vs dye spray chromoendoscopy, the risk of developing...
In this podcast, Jonathan Aviv, MD, talks about the current gold standards for treating gastroesophageal reflux disease, where proton-pump inhibitor therapy fits into the treatment regimen, and...
He discusses the American Journal of Gastroenterology's recent publication of a review of major advancements in gastroenterology over the previous decade.
He talks about his latest research paper in which his team used machine learning to develop a risk-stratification model to predict which patients would experience upper gastrointestinal bleeding and then...
She discusses her study that evaluated internalized stigma in adults with eosinophilic gastrointestinal disorders, evidence-based psychological interventions that are beneficial in reducing this stigma, and...
David T. Rubin, MD, from the University of Chicago, is the chair of the Advances in Inflammatory Bowel Diseases Regional Meeting in Chicago, Illinois. In this podcast, he provides highlights of the upcoming...
Marla Dubinsky, MD, from Icahn School of Medicine at Mount Sinai Hospital, discusses fertility among women with IBD, why managing these patients may not be as simple as it seems, and more.
Stephen Hanauer, MD, from Northwestern Medicine, highlights breakthroughs in autoimmune diseases, the upcoming Interdisciplinary Autoimmune Summit (IAS), and more.
Dr Stephen Hanauer from Northwestern Medicine discusses the roles of TNF inhibitors and immunomodulators in managing IBD, how gastroenterologists can position the use of each therapeutic, and more.
